Back to search results

Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

Abroad (travel likely)Recruiting

Conditions

Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · HER2-Negative Breast Carcinoma · Hormone Receptor-Negative Breast Carcinoma · Triple-Negative Breast Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • MetroHealth, Cleveland, Ohio, United States

    Contact: Study coordinator (Natalie Joseph, MD) · 216-778-7800

  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Samilia Obeng-Gyasi, MD, MPH) · samilia.obeng-gyasi@osumc.edu · 614-293-6408
    Contact: Principal Investigator (Samilia Obeng-Gyasi, MD, MPH)
Study leads

  • Samilia Obeng-Gyasi, MD, MPH

    Principal Investigator

    Ohio State University Comprehensive Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)